A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer-Reference-Cited by-同舟云学术

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

Published:2013-06-02 Issue:7 Volume:45 Page:747-755
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Lunardi Andrea,Ala Ugo,Epping Mirjam T,Salmena Leonardo,Clohessy John G,Webster Kaitlyn A,Wang Guocan,Mazzucchelli Roberta,Bianconi Maristella,Stack Edward C,Lis Rosina,Patnaik Akash,Cantley Lewis C,Bubley Glenn,Cordon-Cardo Carlos,Gerald William L,Montironi Rodolfo,Signoretti Sabina,Loda Massimo,Nardella Caterina,Pandolfi Pier Paolo

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.2650.pdf

Reference49 articles.

1. Nardella, C., Lunardi, A., Patnaik, A., Cantley, L.C. & Pandolfi, P.P. The APL paradigm and the “co-clinical trial” project. Cancer Discov. 1, 108–116 (2011).

2. Catalona, W.J. Management of cancer of the prostate. N. Engl. J. Med. 331, 996–1004 (1994).

3. Molina, A. & Belldegrun, A. Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling. J. Urol. 185, 787–794 (2011).

4. Wang, G. et al. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat. Genet. published online; doi: 10.1038/ng.2654 (2 June 2013).10.1038/ng.2654

5. Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725–730 (2005).

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic hormone-naïve prostate cancer: a distinct biological entity;Trends in Cancer;2024-09

2. Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer;Acta Pharmaceutica Sinica B;2023-12

3. Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities;Research and Reports in Urology;2023-11

4. Generating a Murine PTEN Null Cell Line to Discover the Key Role of p110β-PAK1 in Castration-Resistant Prostate Cancer Invasion;Molecular Cancer Research;2023-08-22

5. Ablative radiotherapy improves survival but does not cure autochthonous mouse models of prostate and colorectal cancer;Communications Medicine;2023-08-09